iiinova — where your digital self keeps evolving

CanVECTOR Network @canvector.bsky.social · 05/05/2025

Attention Trainees: We're accepting applications for our 2025 Studentship Awards (Deadline: May 16th) and Travel Awards (Deadline: May 9th) to #ISTH2025 🎓✈️ Learn more: bit.ly/436JvId #CanVECTOR #VTEresearch #Thrombosis #MedTwitter

042

Reposted by CanVECTOR Network

Thomas Reiser @tomreiser.bsky.social · 24/04/2025

We @ISTH.org greatly value our 🇨🇦 members & colleagues & their important contributions to global #thrombosis & #hemostasis. 🚨 Don't miss this important @canvector.bsky.social CALL FOR APPLICATIONS for Studentship Awards & Travel Awards to #ISTH2025. 📆 Deadline: May 16, 2025 bit.ly/3EAu7va

052

Reposted by CanVECTOR Network

International Society on Thrombosis and Haemostasis @isth.org · 29/01/2025

Calling early-career researchers who submitted an abstract to #ISTH2025! We are accepting apps for the Fundamental Research Career Development Award until March 3! The award is designed to advance the understanding, prevention & treatment of thrombosis and hemostasis: www.isth.org/page/frcda?_...

032

CanVECTOR Network @canvector.bsky.social · 29/01/2025

"Doctor, I am 83 years old and have been taking warfarin for atrial fibrillation. Would switching to a newer blood thinner reduce my risk of bleeding?" New Clot+ patient Evidence Summary now available summarizing the research to this important question. bit.ly/3PVzuar

010

CanVECTOR Network @canvector.bsky.social · 08/01/2025

WEBINAR - Today at 11am ET ! Join us for a special National Thrombosis Seminar on "Incorporating Equity, Diversity, & Inclusion in #VTE #Research Design and Implementation" Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc Register: buff.ly/40kCrGz #Thrombosis

020

Reposted by CanVECTOR Network

Thomas Reiser @tomreiser.bsky.social · 18/12/2024

💡Outstanding mentorship can have a critically positive impact on the lives and careers of #ISTHearlycareer professionals. 👋Help us recognize outstanding mentors through this important @isth-official.bsky.social Award. 🏆 🗓️Application Deadline is January 6! ➡️https://buff.ly/49Im4aW #HemeSky

043

CanVECTOR Network @canvector.bsky.social · 18/12/2024

🎉 Exciting News! 🎉 We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025! Learn more: 🔗 buff.ly/4gHeS1a #Research #Thrombosis #VTE

062

Reposted by CanVECTOR Network

Marc Carrier, MD @marccarriermd.bsky.social · 09/12/2024

Big night for the @uOttawa at #ASH24! Drs. Shaw and Siegal received the Early-Career and Best Paper awards from the Canadian Society of Hematology 🏆 Dr. Shaw’s work on TGA and Dr. Siegal’s on the Stratus trial have been transformative ! Congrats!

3191

Reposted by CanVECTOR Network

Marc Carrier, MD @marccarriermd.bsky.social · 09/12/2024

Measurement of DOACs is challenging. Although the level can influence outcomes, there is no data on dose adjustments. Dr. Siegal also reminded us that standard coagulation tests can provide qualitative assessment but may miss “on-treatment” levels. #ASH24

0121

Reposted by CanVECTOR Network

Marc Carrier, MD @marccarriermd.bsky.social · 08/12/2024

Excellent 🇨🇦representation (including some honorary Canadians 🙃) at @ash-hematology.bsky.social 🏃‍♀️ this morning. Biggest Type Eh! Running group ever!

051